Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

BUY
$79.4 - $116.36 $794 - $1,163
10 Added 13.33%
85 $7,000
Q1 2022

May 09, 2022

BUY
$86.42 - $109.81 $691 - $878
8 Added 11.94%
75 $8,000
Q4 2021

Jan 18, 2022

BUY
$98.56 - $119.91 $689 - $839
7 Added 11.67%
67 $7,000
Q2 2021

Jul 15, 2021

BUY
$86.24 - $95.92 $5,174 - $5,755
60 New
60 $6,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Wolff Wiese Magana LLC Portfolio

Follow Wolff Wiese Magana LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolff Wiese Magana LLC with notifications on news.